Loading Complete
Javier Bolanos Meade

Javier Bolanos Meade, MD

Hematologic Malignancy

Accepting New Patients

Highlights

Age Groups Seen

  • Young Adult 18-25
  • Adult 26-64
  • Older Adult 65+

Languages

  • Spanish
  • English

Gender

Male

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Javier Bolanos Meade

Primary Academic Title

Professor of Oncology

Johns Hopkins Physician

Logo for Johns Hopkins Physician

Background

As a member of the Johns Hopkins Kimmel Cancer Center, my group's research is focused on finding novel therapies for the treatment of both acute and chronic graft versus host disease (GVHD). To that end, we are developing new strategies for prophylaxis as well as therapies for this problem. We are exploring the use of drugs such as pentostatin in steroid refractory GVHD. This drug inhibits an enzyme, called ADA, that induces apoptosis (cell death) of lymphocytes, the effector cells in GVHD. Our results using this approach have been quite encouraging. Also, we are exploring other novel approaches such as extracorporeal photopheresis or high-dose cyclophosphamide. We are participating in the NIH Bone Marrow Transplant Clinical Trials Network consortium to find useful therapies for GVHD. We are also members of the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials on Chronic GVHD, and there we are trying to establish rational guidelines for supportive care, trial design, etc. We run an internationally unique GVHD multidisciplinary clinic with many GVHD experts including a nurse practitioner, research nurse and others from fields such as physical medicine and rehabilitation, gastroenterology, ophthalmology, dermatology, pulmonology and more.

Clinical Trial Keywords

GVHD

Find a Clinical Trial

View all trials by this principal investigator.

Research Interests

GVHD, stem cell transplantation

Selected Publications

  • Bolanos-Meade, J. Update on the management of acute graft-versus-host disease. Curr Opin Oncol. 2006 Mar;18(2):120-125.

    Bolanos-Meade, J.; Hartley, E.; Jones, R.J. Long-term follow-up of allogeneic marrow transplantation for acute myelogenous leukemia after treatment with busulfan and cyclophosphamide. Biol Blood Marrow Transplant. 2006 Mar;12(3):366-367.

    Bolanos-Meade, J.; Vogelsang, G.B. Mesenchymal stem cells and organ transplantation: current status and promising future. Transplantation. 2006 May 27;81(10):1388-1389.

    Couriel, D.; Carpenter, P.A.; Cutler, C.; Bolanos-Meade, J.; Treister, N.S.; Gea-Banacloche, J.; Shaughnessy, P.; Hymes, S.; Kim, S.; Wayne, A.S.; Chien, J.W.; Neumann, J.; Mitchell, S.; Syrjala, K.; Moravec, C.K.; Abramovitz, L.; Liebermann, J.; Berger, A.; Gerber, L.; Schubert, M.; Filipovich, A.H.; Weisdorf, D.; Schubert, M.M.; Shulman, H.; Schultz, K.; Mittelman, B.; Pavletic, S.; Vogelsang, G.B.; Martin, P.J.; Lee, S.J.; Flowers, M.E. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant. 2006 Apr;12(4):375-396.

    Bolanos-Meade, J.; Anders, V.; Wisell, J.; Farmer, E.R.; Vogelsang, G.B. Grover's Disease after Bone Marrow Transplantation. Biol Blood Marrow Transplant. 2007 Sep;13(9):1116-1117.

    Bolanos-Meade, J.; Garrett-Mayer, E.; Luznik, L.; Anders, V.; Webb, J.; Fuchs, E.J.; Huff, C.A.; Matsui, W.; Borrello, I.M.; Brodsky, R.; Kasamon, Y.L.; Swinnen, L.J.; Flinn, I.W.; Ambinder, R.F.; Jones, R.J.; Hess, A.D.; Vogelsang, G.B. Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma. Biol Blood Marrow Transplant. 2007 Oct;13(10):1185-1191.

    Bolanos-Meade, J.; Vogelsang, G.B. Montelukast in chronic graft-versus-host disease: a breath of fresh air Transplantation. 2007 Mar 15;83(5):527-528.

    Jacobsohn, D.A.; Chen, A.R.; Zahurak, M.; Piantadosi, S.; Anders, V.; Bolanos-Meade, J.; Higman, M.; Margolis, J.; Kaup, M.; Vogelsang, G.B. Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. J Clin Oncol. 2007 Sep 20;25(27):4255-4261.

    Loyo, M.; Quintanilla-Dieck Mde, L.; Stein, B.; Bolanos-Meade, J. Bilateral subdural hematoma after hematopoietic stem cell transplantation: a diagnosis often overlooked. Leuk Lymphoma. 2007 Apr;48(4):835-836.

    Bolanos-Meade, J.; Vogelsang, G.B. Chronic graft-versus-host disease. Curr Pharm Des. 2008;14(20):1974-1986.

    Brodsky, R.A.; Luznik, L.; Bolanos-Meade, J.; Leffell, M.S.; Jones, R.J.; Fuchs, E.J. Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases. Bone Marrow Transplant. 2008 Oct;42(8):523-527.

    Luznik, L.; O'Donnell, P.V.; Symons, H.J.; Chen, A.R.; Leffell, M.S.; Zahurak, M.; Gooley, T.A.; Piantadosi, S.; Kaup, M.; Ambinder, R.F.; Huff, C.A.; Matsui, W.; Bolanos-Meade, J.; Borrello, I.; Powell, J.D.; Harrington, E.; Warnock, S.; Flowers, M.; Brodsky, R.A.; Sandmaier, B.M.; Storb, R.F.; Jones, R.J.; Fuchs, E.J. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008 Jun;14(6):641-650.

    Alousi, A.M.; Weisdorf, D.J.; Logan, B.R.; Bolanos-Meade, J.; Carter, S.; Difronzo, N.; Pasquini, M.; Goldstein, S.C.; Ho, V.T.; Hayes-Lattin, B.; Wingard, J.R.; Horowitz, M.M.; Levine, J.E. Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. Blood. 2009 Jul 16;114(3):511-517.

    Bolanos-Meade, J.; Brodsky, R.A. Blood and marrow transplantation for sickle cell disease: overcoming barriers to success. Curr Opin Oncol. 2009 Mar;21(2):158-161.

    Bolanos-Meade, J.; Luznik, L.; Muth, M.; Matsui, W.H.; Huff, C.A.; Smith, B.D.; Levy, M.Y.; Kasamon, Y.L.; Swinnen, L.J.; Powell, J.D.; Brodsky, R.A.; Ambinder, R.F.; Jones, R.J.; Fuchs, E.J. Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen. Bone Marrow Transplant. 2009 Mar;43(6):477-480.

    Fuchs, E.J.; Luznik, L.; Bolanos-Meade, J.; Miller, C.B.; Brodsky, R.A.; Ambinder, R.F.; Jones, R.J. Successful pregnancy and childbirth after reduced-intensity conditioning and partially HLA-mismatched BMT. Bone Marrow Transplant. 2009 Jun;43(12):969-970.

    Kasamon, Y.L.; Luznik, L.; Leffell, M.S.; Kowalski, J.; Tsai, H.L.; Bolanos-Meade, J.; Morris, L.E.; Crilley, P.A.; O'Donnell, P.V.; Rossiter, N.; Huff, C.A.; Brodsky, R.A.; Matsui, W.H.; Swinnen, L.J.; Borrello, I.; Powell, J.D.; Ambinder, R.F.; Jones, R.J.; Fuchs, E.J. Nonmyeloablative HLA-Haploidentical BMT with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome. Biol Blood Marrow Transplant. 2009 Nov 16.

    Kasamon, Y.L.; Wahl, R.L.; Ziessman, H.A.; Blackford, A.L.; Goodman, S.N.; Fidyk, C.A.; Rogers, K.M.; Bolanos-Meade, J.; Borowitz, M.J.; Ambinder, R.F.; Jones, R.J.; Swinnen, L.J. Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning. Biol Blood Marrow Transplant. 2009 Feb;15(2):242-248.

    Bolanos-Meade, J.; Smith, B.D.; Gore, S.D.; McDevitt, M.A.; Luznik, L.; Fuchs, E.J.; Jones, R.J. 5-Azacytidine as Salvage Treatment in Relapsed Myeloid Tumors after Allogeneic Bone Marrow Transplantation. Biol Blood Marrow Transplant. 2010 Oct 15;In Press.

    Karp, J.E.; Blackford, A.; Smith, B.D.; Alino, K.; Seung, A.H.; Bolanos-Meade, J.; Greer, J.M.; Carraway, H.E.; Gore, S.D.; Jones, R.J.; Levis, M.J.; McDevitt, M.A.; Doyle, L.A.; Wright, J.J. Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia. Leuk Res. 2010 Jul;34(7):877-882.

    Kasamon, Y.L.; Luznik, L.; Leffell, M.S.; Kowalski, J.; Tsai, H.L.; Bolanos-Meade, J.; Morris, L.E.; Crilley, P.A.; O'Donnell, P.V.; Rossiter, N.; Huff, C.A.; Brodsky, R.A.; Matsui, W.H.; Swinnen, L.J.; Borrello, I.; Powell, J.D.; Ambinder, R.F.; Jones, R.J.; Fuchs, E.J. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transplant. 2010 Apr;16(4):482-489.

    Luznik, L.; Bolanos-Meade, J.; Zahurak, M.; Chen, A.R.; Smith, B.D.; Brodsky, R.; Huff, C.A.; Borrello, I.; Matsui, W.; Powell, J.D.; Kasamon, Y.; Goodman, S.N.; Hess, A.; Levitsky, H.I.; Ambinder, R.F.; Jones, R.J.; Fuchs, E.J. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood. 2010 Apr 22;115(16):3224-3230.

    Bolanos-Meade, J., and Vogelsang, G.B. (2008). Chronic graft-versus-host disease. Curr Pharm Des 14, 1974-1986.

    Brodsky, R.A., Luznik, L., Bolanos-Meade, J., Leffell, M.S., Jones, R.J., and Fuchs, E.J. (2008). Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases. Bone Marrow Transplant 42, 523-527.

    Luznik, L., O''Donnell, P.V., Symons, H.J., Chen, A.R., Leffell, M.S., Zahurak, M., Gooley, T.A., Piantadosi, S., Kaup, M., Ambinder, R.F., Huff, C.A., Matsui, W., Bolanos-Meade, J., Borrello, I., Powell, J.D., Harrington, E., Warnock, S., Flowers, M., Brodsky, R.A., Sandmaier, B.M., Storb, R.F., Jones, R.J., and Fuchs, E.J. (2008). HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 14, 641-650.

    Bolanos-Meade, J., and G. B. Vogelsang. 2007. Montelukast in chronic graft-versus-host disease: a breath of fresh air? Transplantation 83:527-8.

    Bolanos-Meade, J., E. Garrett-Mayer, L. Luznik, V. Anders, J. Webb, E. J. Fuchs, C. A. Huff, W. Matsui, I. M. Borrello, R. Brodsky, Y. L. Kasamon, L. J. Swinnen, I. W. Flinn, R. F. Ambinder, R. J. Jones, A. D. Hess, and G. B. Vogelsang. 2007. Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma. Biol Blood Marrow Transplant 13:1185-91.

    Bolanos-Meade, J., V. Anders, J. Wisell, E. R. Farmer, and G. B. Vogelsang. 2007. Grover''s Disease after Bone Marrow Transplantation. Biol Blood Marrow Transplant 13:1116-7.

    Jacobsohn, D. A., A. R. Chen, M. Zahurak, S. Piantadosi, V. Anders, J. Bolanos-Meade, M. Higman, J. Margolis, M. Kaup, and G. B. Vogelsang. 2007. Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. J Clin Oncol 25:4255-61.

    Loyo, M., L. Quintanilla-Dieck Mde, B. Stein, and J. Bolanos-Meade. 2007. Bilateral subdural hematoma after hematopoietic stem cell transplantation: a diagnosis often overlooked. Leuk Lymphoma 48:835-6.

    Bolanos-Meade, J. & Vogelsang, G. B. (2006). Mesenchymal stem cells and organ transplantation: current status and promising future. Transplantation 81, 1388-9.

    Bolanos-Meade, J. (2006). Update on the management of acute graft-versus-host disease. Curr Opin Oncol 18, 120-5.

    Bolanos-Meade, J., Hartley, E. & Jones, R. J. (2006). Long-term follow-up of allogeneic marrow transplantation for acute myelogenous leukemia after treatment with busulfan and cyclophosphamide. Biol Blood Marrow Transplant 12, 366-7.

    Couriel, D., Carpenter, P. A., Cutler, C., Bolanos-Meade, J., Treister, N. S., Gea-Banacloche, J., Shaughnessy, P., Hymes, S., Kim, S., Wayne, A. S., Chien, J. W., Neumann, J., Mitchell, S., Syrjala, K., Moravec, C. K., Abramovitz, L., Liebermann, J., Berger, A., Gerber, L., Schubert, M., Filipovich, A. H., Weisdorf, D., Schubert, M. M., Shulman, H., Schultz, K., Mittelman, B., Pavletic, S., Vogelsang, G. B., Martin, P. J., Lee, S. J. & Flowers, M. E. (2006).

    Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 12, 375-96.



    Bolaos-Meade, J., Zhou, L., Hoke, A., Corse, A., Vogelsang, G.,Wagner, K. R. In press. Hydroxychloroquine causes a severe vacuolar myopathy in a patient with chronic graft-versus-host disease. Am J Hematol.

    Bolaos-Meade, J., Ioffe, O., Hey, J., Vogelsang, G. B., Akpek, G. In press. Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung. Am J Hematol.

    Bolaos-Meade, J., Jacobsohn, D. A., Margolis, J., Ogden, A., Wientjes, M. G., Byrd, J. C., Lucas, D. M., Anders, V., Phelps, M., Grever, M. R., Vogelsang, G. B. In press. Pentostatin in steroid refractory acute graft-versus-host disease. J Clin Oncol.

Locations

  1. Sidney Kimmel Comprehensive Cancer Center
    • 401 North Broadway Street, Weinberg BLDG, Baltimore, MD 21287
    • Get Directions

Expertise

Education

  • Fellowship: Johns Hopkins University School of Medicine, 2003
  • Fellowship: University of Maryland Medical Center, Hematology and Oncology, 2002
  • Residency: Texas Tech University Health Lubbock, Internal Medicine, 1999
  • Medical Education: Universidad de Monterrey Facultad de Medicina, MD, 1995

Insurance

Please contact the location directly to confirm your health plan is accepted.
Search plans
  • Aetna
  • CareFirst
  • Cigna
  • First Health
  • Geisinger Health Plan
  • HealthSmart/Accel
  • Johns Hopkins Health Plans
  • MultiPlan
  • Pennsylvania's Preferred Health Networks (PPHN)
  • Point Comfort Underwriters
  • Private Healthcare Systems (PHCS)
  • Veteran Affairs Community Care Network (Optum-VACCN)

Ratings & Reviews

5 out of 5

36 ratings, 13 reviews

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Overall Rating by Patient
Provider Listened Carefully
Provider Explained Things Clearly
Provider Knew Medical History
Provider Showed Respect
Provider Spent Enough Time
Search reviews
    5 out of 5 stars
    Reviewed on 3/12/2026

    Excellent

    5 out of 5 stars
    Reviewed on 3/9/2026

    I have been very fortunate to have the care from Dr. J. Meade office.

    5 out of 5 stars
    Reviewed on 2/27/2026

    Wonderful visit with a very knowledgeable doctor.

    5 out of 5 stars
    Reviewed on 2/9/2026

    Ever one kind and good to me

    5 out of 5 stars
    Reviewed on 1/12/2026

    Dr. Meade ranks with the best that Johns Hopkins provides. Smart, Intuitive, enormously kind and caring, there is simply none better!!!

    5 out of 5 stars
    Reviewed on 12/19/2025

    VERY PROFESSIONAL AND KNOWLEDGEABLE

    5 out of 5 stars
    Reviewed on 9/25/2025

    He is a very good specialist doctor and is always attentive to any comment I make regarding my disease

    5 out of 5 stars
    Reviewed on 9/19/2025

    VERY PROFESSIONAL AND WARM A

    5 out of 5 stars
    Reviewed on 9/8/2025

    A prince among men and doctors! Only think of him in ""Superlatives!""

    5 out of 5 stars
    Reviewed on 7/18/2025

    he is exceptional.

    5 out of 5 stars
    Reviewed on 6/5/2025

    Excellent

    5 out of 5 stars
    Reviewed on 5/12/2025

    Dr. Meade is conscientious, knowledgeable, empathic, and has a charming personality. He is always punctual and considerate. He is also extremely responsive, and timely, with respect to responses to my MyChart messages and questions, which really is notable and appreciated.

    5 out of 5 stars
    Reviewed on 5/8/2025

    Dr Meade really explained everything about my condition very well and was very helpful